Author

T. C. Voss

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:electrophysiology· 1

Frequent Co-Authors

A. D. White· 1 shared A. Simeonov· 1 shared B. L. Roth· 1 shared C. A. Tristan· 1 shared C. Bonney· 1 shared C. Malley· 1 shared D. Dorjsuren· 1 shared E. Barnaeva· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. D. White

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 in vitro activity

R. T. Eastman, R. Rusinova, K. F. Herold, X.-P. Huang, P. Dranchak, T. C. Voss, S. Rana, J. H. Shrimp, A. D. White, H. C. Hemmings, B. L. Roth, J. Inglese, O. S. Andersen, J. L. Dahlin

This study shows ivermectin reduces SARS-CoV-2 viral burden in vitro but at concentrations that also cause cytotoxicity, suggesting its antiviral effect may be due to nonspecific membrane perturbation rather than specific antiviral activity.

bioRxiv · Oct 23, 2023 · PreprintPharmacology & Toxicology

Robotic High-Throughput Biomanufacturing and Functional Differentiation of Human Pluripotent Stem Cells

C. A. Tristan, P. Ormanoglu, J. Slamecka, C. Malley, P.-H. Chu, V. M. Jovanovic, Y. Gedik, C. Bonney, E. Barnaeva, J. Braisted, S. K. Mallanna, D. Dorjsuren, M. J. Iannotti, T. C. Voss, S. Michael, , I. Singec

This paper develops a robotic platform for high-throughput manufacturing and differentiation of human pluripotent stem cells, validated through molecular and functional analyses.

bioRxiv · Aug 3, 2020Bioengineering